Diethyl Sulfide

Diethyl Sulfide

SCHEMBL869475

CCSCC.F.F.F

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113748184-B Boron-containing cyclic light-emitting compound and color conversion film containing same 日东电工株式会社 2025-04-04 CN disclosed
CN-118307532-A N2 substituted triazole-oxazoline chiral compound and preparation method and application thereof 吉林大学 2024-07-09 CN disclosed
CN-116096712-A Novel compounds NRG治疗有限公司 2023-05-09 CN disclosed
CN-111315750-B Pyridopyrimidines as mTORC1/2 dikinase inhibitors 南京明德新药研发有限公司 2022-12-23 CN disclosed
US-11377444-B2 Pyridopyrimidine compounds acting as mTORC 1/2 dual inhibitors MEDSHINE DISCOVERY INC. (CN) 2022-07-05 US disclosed
EP-3489233-B1 INDOLE DERIVATIVE USED AS CRTH2 INHIBITOR CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD (CN) 2022-01-12 EP disclosed
CN-113748184-A Boron-containing cyclic light-emitting compound and color conversion film containing the same 日东电工株式会社 2021-12-03 CN disclosed
CN-113286594-A Application of pyridopyrimidine compound in preparation of medicine for treating nasopharyngeal carcinoma 南京明德新药研发有限公司 2021-08-20 CN disclosed
US-20200339568-A1 PYRIDOPYRIMIDINE COMPOUNDS ACTING AS MTORC 1/2 DOUBLE-KINASE INHIBITORS MEDSHINE DISCOVERY INC. (CN) 2020-10-29 US disclosed
US-10800765-B2 Indole derivative used as CRTH2 inhibitor CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) 2020-10-13 US disclosed
CN-1886400-A 9, 10-alpha, alpha-OH taxane analogs and methods of making the same TAPESTRY PHARMACEUTICALS INC (US) 2006-12-27 CN disclosed
EP-1664033-A4 9,10-ALPHA,ALPHA-OH-TAXANE ANALOGS AND METHODS FOR PRODUCTION THE REOF TAPESTRY PHARMACEUTICALS INC (US) 2006-09-13 EP disclosed
EP-1664033-A2 9,10-ALPHA,ALPHA-OH-TAXANE ANALOGS AND METHODS FOR PRODUCTION THE REOF Tapestry Pharmaceuticals, Inc. (US) 2006-06-07 EP disclosed
EP-1656379-A1 4-CYCLOALKYLAMINOPYRAZOLO PYRIMIDINE NMDA/NR2B ANTAGONISTS Merck & Co., Inc. (US) 2006-05-17 EP disclosed
US-20050148657-A1 alpha stereochemistry at the C-9 and C-10 OH positions offers excellent inhibition of cell growth against MDR sensitive cancer cell lines; starting materials are Paclitaxel and Docetaxel; increased biological activity; side effect reduction; solubility; better therapeutic profile; anticancer TAPESTRY PHARMACEUTICALS, INC. 2005-07-07 US disclosed
WO-2005030150-A2 9,10-α,α-OH-TAXANE ANALOGS AND METHODS FOR PRODUCTION THEREOF TAPESTRY PHARMACEUTICALS, INC. (US) 2005-04-07 WO disclosed
US-20050054658-A1 4-Cycloalkylaminopyrazolo pyrimidine NMDA/NR2B antagonists THOMPSON WAYNE (US) 2005-03-10 US disclosed
WO-2005019222-A1 4-CYCLOALKYLAMINOPYRAZOLO PYRIMIDINE NMDA/NR2B ANTAGONISTS MERCK & CO., INC. (US) 2005-03-03 WO disclosed
WO-2005019221-A1 4-CYCLOALKYLAMINOPYRAZOLO PYRIMIDINE NMDA/NR2B ANTAGONISTS MERCK & CO., INC. (US) 2005-03-03 WO disclosed
CN-1157822-A Pharmaceutical compounds LILLY INDUSTRIES LTD (GB) 1997-08-27 CN disclosed